Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(15 sites)

United States

Southwest Autism Research & Resource Center, Phoenix, Arizona

Amnova Clinical Research, LLC, Irvine, California

Children's Hospital of Orange County - Pediatric Subspecialty, Orange, California

Uc Davis Mind Institute, Sacramento, California

Children's Hospital Colorado, Aurora, Colorado

Neurology, Miami, Florida

Emory University - The Emory Clinic - Clifton Road, Atlanta, Georgia

Rush University Medical Center-Clinical Operation, Chicago, Illinois

Kennedy Krieger Institute, John Hopkins School of Medicine, Baltimore, Maryland

Boston Children's Hospital, Boston, Massachusetts

UMass Memorial Health, Worcester, Massachusetts

University of Minnesota Department of Medicine, Minneapolis, Minnesota

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Suburban Research Associates, Media, Pennsylvania

Intermountain Healthcare - Park City Specialty Clinic, Salt Lake City, Utah